HBA-MSH C.S.H.B. 3155 77(R)BILL ANALYSIS Office of House Bill AnalysisC.S.H.B. 3155 By: Capelo Public Health 4/10/2001 Committee Report (Substituted) BACKGROUND AND PURPOSE According to the American Diabetes Association, 15.7 million people or 5.9 percent of the population of the United States have diabetes. One child out of every 600 develops Type 1 diabetes. The Texas Department of Health estimates that in 1998, 1.6 million adult Texans or 12 percent of the state's population had diabetes. It is estimated that in 1990 there were 9,320 Texans under age 18 who had Type 1 diabetes. From 1993 to 1998, the number of children under age 18 with type 2 diabetes tripled. Diabetes can produce complications such as blindness, kidney disease, nerve damage, heart disease, and stroke. Many of the components associated with the disease are unknown and need further research. C.S.H.B. 3155 requires the commissioner of health in consultation with the Texas Diabetes Council to establish a Pediatric Diabetes Research Advisory Committee to develop of a plan to investigate the scientific research opportunities for pediatric diabetes. RULEMAKING AUTHORITY It is the opinion of the Office of House Bill Analysis that this bill does not expressly delegate any additional rulemaking authority to a state officer, department, agency, or institution. ANALYSIS C.S.H.B. 3155 requires the commissioner of health (commissioner) in consultation with the Texas Diabetes Council to establish a pediatric diabetes research advisory committee (advisory committee) and sets forth requirements for the composition of the committee. The bill requires the advisory committee to conduct analyses and assessments for the purpose of providing advice to the legislature and governor on the development of a plan to investigate the scientific research opportunities for pediatric diabetes in the state as well as to assess resources, talent, and the economic and health-related diabetes burden. The bill requires the advisory committee to submit a report to the governor, lieutenant governor, and speaker of the house or representatives not later than December 1, 2002. The bill sets forth provisions relating to the composition and appointment of members of the advisory committee as well as the appointment of a chair by the commissioner. The bill provides for the termination of the group on January 1, 2003. EFFECTIVE DATE On passage, or if the Act does not receive the necessary vote, the Act takes effect September 1, 2001. COMPARISON OF ORIGINAL TO SUBSTITUTE C.S.H.B. 3155 differs from the original by changing the name of the entity created by the bill from the pediatric diabetes research-plan group to the pediatric diabetes research advisory committee (advisory committee). The substitute specifies to whom the advisory committee's report is to be submitted and the deadline for the submission. The substitute provides for the abolition of the advisory committee on January 1, 2003 and changes the effective date of the bill from 90 days after adjournment to the date of passage. The substitute conforms the original to Texas Legislative Council style and format.